Fondazione Italiana Linfomi - Ets

This study tests a drug called glofitamab in 41 people with mantle cell lymphoma whose cancer did not respond or came back after CAR T-cell therapy. The goal is to see if glofitamab can shrink or control the cancer. Participants will receive the drug and be monitored for response…

This study tests a daily pill called pirtobrutinib in elderly patients (70+) with mantle cell lymphoma who are too frail for standard chemotherapy. The goal is to see if the drug can control the cancer and delay its progression. About 56 participants will take the drug until thei…

This study looks at whether people with early-stage Hodgkin lymphoma who respond well to two cycles of chemotherapy can safely receive a lower dose of radiation (20 Gy instead of the usual 30 Gy). About 518 adults will take part. The goal is to see if the lower dose works just as…

This study looks at whether adding a geriatric-guided care plan—including nutrition, physical, and social support—to standard cancer treatment can improve quality of life for older adults (70+) with diffuse large B-cell lymphoma. About 170 participants will be assigned to either …

This study looks back at 100 people with a rare type of lymphoma (sALCL) who received a new targeted therapy combined with chemotherapy (BV-CHP). Researchers want to see how well the treatment works in real-world settings and understand why some patients respond better than other…

This study follows 100 adults with certain types of lymphoma who are receiving CAR-T cell therapy. Researchers will test their thinking, memory, and quality of life before treatment and again at 6, 12, and 24 months after. The goal is to understand how the therapy affects brain f…